Spartanamicin B(134910-04-6)
- Name: Spartanamicin B
- Synonyms:1-Naphthacenecarboxylicacid,2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7,10-tetrahydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R-trans)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-a-L-lyxo-hexopyranosyl]-3-(dimethylamino)-a-L-lyxo-hexopyranosyl]oxy]-,methyl ester, [1R-(1a,2b,4b)]-; Cinerubin A (8CI); 1-Hydroxyaclacinomycin A;Antibiotic MA 144A2; Ciclamycin 5; Cinerubine A; MA 144A2; NSC 18334; NSC243022; Rhodirubin C; Spartanamicin B
- Molecular Formula:C42H53 N O16
- Molecular Weight:827.86732
- CAS Registry Number:134910-04-6
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.134910-04-6 Spartanamicin B
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
Other Product
- 5546-63-4/2-chloro-4-nitro-N-[4-(1,3-thiazol-2-ylsulfamoyl)phenyl]benzamide
- 39804-96-1/1-cyclohexyl-3-methylurea
- 120399-17-9/potassium {[(2-nitro-1H-imidazol-1-yl)acetyl]amino}oxidanide
- 4251-91-6/(2S,3S)-2,3-bis[(ethoxycarbonyl)oxy]butane-1,4-diyl dimethanesulfonate
- 143380-86-3/1-Butanone, 4-(3-methyl-1-piperidinyl)-1-(2-thienyl)-, hydrochloride
- 151581-62-3/hemoglobin Hradec Kralove
- 52303-01-2/1,4-dihydroxy-5,8-bis(phenylamino)anthraquinone
- 136105-79-8/6-(3,5-dimethylbenzyl)-5-ethyl-1-[(2-hydroxyethoxy)methyl]pyrimidine-2,4(1H,3H)-dione
- 7598-86-9/2-(dimethylamino)-1,2,3,4-tetrahydrophenanthren-1-ol
- 105458-01-3/2-Butenedioic acid (Z)-, monomethyl ester, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, hexahydro-2H-azepin-2-one and 1,1'-methylenebis[4-isocyanatobenzene]
- 60521-72-4/ethyl 3-[3-(2-ethoxycarbonylethynyl)phenyl]prop-2-ynoate
- 62017-46-3/8,19-Cyclo-9,10-secocholestane
- 59067-33-3/BAY-SIR 6874
- 68896-40-2/[(9R,10S,13R,17R)-7,15-dichloro-17-[(1R)-1,5-dimethylhexyl]-10,13-dimethyl-2,3,4,5,6,7,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] benzoate
- 139542-65-7/Hostalub TP-WE 5
- 28748-76-7/Pyrrolo(3,2,1-jk)(1,4)benzodiazepin-4(3H)-one, 6,7-dihydro-9-nitro-1-p henyl-
- 68915-57-1/Dimer acid, hydrogenated, caprolactam, ethylenediamine terpolymer
- 29082-33-5/7-nitroquinolin-8-yl 3-propoxybenzoate
- 61421-82-7/N-(4-methoxyphenyl)acridin-9-amine
- 134910-04-6/Spartanamicin B
- 59822-58-1/2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate and N-(hydroxymethyl)-2-propenamide
- 58024-45-6/1-[1-(3,4-dimethoxyphenyl)ethenyl]-6,7-dimethoxyisoquinoline
- 25474-11-7/7-(β-D-Glucopyranosyloxy)-4',5-dihydroxy-3',6-dimethoxyflavone
- 1544-46-3/Fluoroacetaldehyde
- 51989-25-4/8-deazafolic acid
- 63679-55-0/1-Acetyl-2-(2-aminoethyl)-isothiouronium acetate
- 28731-85-3/1,3,5-Triazine-2,4-diamine,N2,N4-bis(4-aminophenyl)-6-chloro-
- 75847-64-2/ethyl (1-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)acetate hydrochloride (1:1)
- 2051-96-9/Benzyl lactate
- 18157-17-0/2-CHLOROETHOXYTRIMETHYLSILANE